 SOUTH SAN FRANCISCO, Calif., Feb. 03, 2022 GLOBE NEWSWIRE -- CareDx, Inc. Nasdaq: CDNA The Transplant CompanyTM focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers today announced that the Company will participate in the BTIG Virtual MedTech, Digital Health, Life Science Diagnostic Tools Conference and the Raymond James 43rd Annual Institutional Investors Conference. 